Agency’s comprehensive risk evaluations find unreasonable risks requiring regulatory action

December 31, 2025 Contact Information EPA Press Office (press@epa.gov) WASHINGTON – U.S. Environmental Protection Agency (EPA) announced today that it will move to regulate dozens of applications of five widely used phthalate chemicals to address environmental and workplace risks. This decision is based on final risk evaluations, released today, for each of these chemicals: Butyl Benzyl Phthalate (BBP),…

EPA Announces Intent to Regulate Nearly One Dozen 1,3-Butadiene Uses to Protect American Workers

December 31, 2025 Contact Information EPA Press Office (press@epa.gov) WASHINGTON – In compliance with a court ordered deadline, U.S. Environmental Protection Agency (EPA) completed a robust review of 1,3-butadiene using gold standard science. We used the best research, data, and testing available, along with input from the public and independent expert peer reviewers to complete this thorough…

FDA Cosmetics

FDA Finds Insufficient Data to Determine Safety of PFAS in Cosmetic Products

Featured image republished from FDA news release. Today, the U.S. Food and Drug Administration today released a congressionally mandated report under the Modernization of Cosmetics Regulation Act of 2022 (MoCRA) evaluating the use of perfluoroalkyl and polyfluoroalkyl substances (PFAS) in cosmetic products. While the report reviews available scientific evidence on potential safety concerns, the FDA’s…

OEL

Occupational Exposure Assessment: Protecting Worker Health Through Science

Occupational exposure assessment is a cornerstone of occupational and environmental health. It provides the evidence needed to understand how workers come into contact with hazardous agents and guides decisions that protect health, improve workplace safety, and ensure regulatory compliance. Whether addressing chemical, physical, or biological hazards, exposure assessment transforms workplace observations into actionable data. What…

SDS Pharma

How SDS Authoring Supports Pharmaceutical Product Safety

Safety Data Sheets (SDSs) are often associated with industrial chemicals, manufacturing environments, or laboratory operations—but they play an equally critical role in the pharmaceutical sector. From active pharmaceutical ingredients (APIs) to excipients and intermediates, properly authored SDSs help protect workers, ensure regulatory compliance, and strengthen product stewardship throughout the drug-development lifecycle. In an industry where…

only representative

Understanding the Role of an Only Representative under EU REACH

    Understanding the Role of an Only Representative under EU REACH The European Union’s Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) regulation is one of the most comprehensive chemical regulatory frameworks in the world. Designed to protect human health and the environment, EU REACH places strict requirements on companies manufacturing or importing substances…

EPA Proposes Changes to Make PFAS Reporting Requirements More Practical and Implementable, Reducing Regulatory Burden

Today, U.S. Environmental Protection Agency (EPA) released a proposal to improve the scope of its perfluoroalkyl and polyfluoroalkyl substances (PFAS) reporting regulations under the Toxic Substances Control Act (TSCA) to make them more practical and implementable and reduce unnecessary, or potentially duplicative, reporting requirements for businesses while maintaining the ability to obtain important use and…

only representative

Understanding the Role of an Only Representative under UK REACH

When the United Kingdom left the European Union, it brought significant regulatory changes—especially for the chemical industry. With UK REACH now operating as an independent system, companies manufacturing or supplying substances to the UK market must ensure compliance under this separate regime. For non-UK manufacturers, one of the most effective ways to remain compliant is…